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high levels which results in necrosis of the gut mucosa, notably caused by toxins [4, 5] . Some conditions that allow CP to overgrow and compromise the GIT are known and may include, but not limited to, Eimeria maxima (EM) infection, animal-based protein meal products, and feedstuffs containing high levels on non-starch polysaccharides [4, 6, 7] . As a multifactorial disease, research related to NE is riddled with a variety of disparate methodologies and conclusions often contradict previous results from other researchers. Repeatable disease models provide the most conclusive information on predisposing factors of NE and how to mitigate the disease [8] .
While many laboratories have developed models to study NE, they often vary in methods of inducing NE-promoting GIT conditions and bacterial administration protocols. For example, Salmonella enterica serovars present in the GIT can lead to increased susceptibility to NE, presumably due to low levels of tissue inflammation, and has been implemented as a means to stimulate NE in some research models [9] . Additionally, co-infection of CP and Eimeria species has been employed to create NE, by disrupting GIT homeostasis via induction of coccidiosis [10] . Several labs have successfully developed dual infection models that combine CP and Eimeria [11] [12] [13] . However, whether different strains of EM have varying effects on the onset of NE has not been well studied. Thus, the objectives of these experiments were to compare several methods of NE induction through a variety of CP isolates with or without EM and means of CP administration by measuring BW parameters and macroscopic GIT lesions.
MATERIALS AND METHODS

Animals, Housing, and Experimental Design
In all experiments, day-of-hatch Ross708 broiler chicks were obtained from a local hatchery, neck-tagged and randomly placed into pens with fresh pine shaving litter [14] . Nutritionally complete un-medicated feed and water were provided ad libitum, except where noted below [15] . All animal handing protocols were in compliance with the Institutional Animal Care and Use Committee at The Ohio State University.
Bacterial Preparation
For all experiments, Salmonella enterica serovar Enteritidis (SE) was prepared and administered on day of hatch to all chicks, except for the non-challenged negative control group (NC), as described by Shivaramaiah and coauthors [9, 16] . The administration of Salmonella at day of hatch has been shown to increase the pathogenicity of NE in the research setting, and inclusion in treated groups may better mimic the intestinal environment of chicks raised in a commercial broiler house [9, 17, 18] . The challenge dose was retrospectively confirmed by plating 10-fold dilutions on tryptic soy agar (TSA), as described [16, 19] and are reported in data tables.
All CP isolates were acquired from clinical cases of NE, and species confirmation was determined by culture characteristics, Gram-stain, and PCR detection of select CP genes [20] . For all experiments, CP was prepared and administered at different concentrations and days, see each experiment section below for more detail (Table 2) . To prepare inoculum, a single frozen aliquot of each strain was inoculated into individual tubes with tryptic soy broth (TSB) with 0.25% sodium thioglycolate, and incubated in anaerobic jars at 37
• C for up to 24 h [21] [22] [23] [24] . Cultures administered via oral gavage were washed by centrifugation and quantified on a spectrophotometer [25, 26] . All CP challenge doses were retrospectively confirmed by plating 10-fold dilutions on TSA with sodium thioglycolate, and values are reported below.
PCR Detection of CP Toxin Genes
Extraction and purification of DNA from pure CP cultures followed the protocol of AmitRomach et al. with modifications [20, 27] , and DNA was quantified and quality measured on a microvolume spectrophotometer [28] . Primers to detect CP toxin genes are described in Table 1 . The PCR amplification conditions for targeted genes were 2-5 min at 94
• C, followed by 35 cycles of 30 s at 94
• C, 30 s at annealing temperature, and 30 s at 72
• C, followed by an elongation phase of 72
• C for 10 min. Aliquots of 10 μL for each PCR product were electrophoretically separated on a 1.5% TBE electrophoresis 4 Total of 1 L of either unwashed CPB1 (unwashed), washed CPB1 (washed), or supernatant from CPB1 washed (supernatant)
were combined with 1 kg of the treatments respective feed twice a day, values reported as total CFU administered in the feed.
gel to confirm presence or absence of the targeted genes.
In-feed Administration of Clostridium
Treatment inoculum in experiments 2, 3, and 4, for which CP was administered in feed, was prepared by growing each strain separately in independent tubes, with a fresh culture prepared each day. Similar to Jiang et al. [29] , CP administered in the feed was not washed by centrifugation, except where noted as "washed." To prepare supernatant treatment inoculum, once centrifuged, supernatant was collected while the pellet was centrifuged 2 more times to prepare inoculum for washed groups. For combined strains of CP administered in the feed, equal amounts were mixed into a common container prior to washing by centrifugation, as described [25] . All CP treatments were diluted with TSB with thioglycolate and quantified spectrophotometrically [23, 24, 26]. The desired volume of each CP strain in TSB with thioglycolate, as described in each experiment section below (Table 2) , was administered and mixed in the feed trough or placed on multiple cookie sheets of each treatment pen.
Experiment 1
A total of 48 day-of-hatch broilers were randomly assigned to 1 of the 4 following treatments (n = 12 each): non-inoculated control (NC), Eimeria maxima strain Guelph (EMG) + CP NetB-negative strain (CP1), treatment name EMG, EMG + CP1 + 50 ppm of bacitracin methylene disalicylate (BMD), or CP NetBpositive strain (CPB1). All Eimeria were quantified prior to each challenge [30] . On day 18, 50,000 oocysts of EMG were administered by oral gavage to EMG and BMD groups, followed by 2.7 × 10 8 CFU/chick CP1 on day 22. The CPB1 treatment received 2.5 × 10 6 CFU/chick of CPB1 via oral gavage on day 19. On day 24, all birds were euthanized via CO 2 inhalation for BW and gross macroscopic NE lesion score evaluation. Necrotic enteritis lesions were evaluated in the small intestine on a scale of 0-4, as previously described [31].
Experiment 2
As a next preliminary experiment to compare of NE research models, test groups included methodologies described by Shivaramaiah and coauthors [9] or, a modified version of Jiang and coauthors [29] . A total of 100 day-of-hatch broilers were randomly assigned to 1 of the 5 following treatments (n = 20 each): NC, CP1, or 1 of 3 NetB-positive strains, CPB1, CPB2, or CPB3. At day of placement to 5 d prior to CP challenge, the diet included 50 ppm salinomycin, and NC remained on medicated feed for the entirety of the trial. To confirm Eimeria-free rooms, 5 d prior to NE administration, fresh fecal samples from each pen were collected daily and evaluated by standard fecal flotations from all pens to confirm absence of Eimeria oocysts.
Beginning on day 16, all CP groups were challenged with 50 mL that contained approximately 10 8 CFU/mL of their respective CP strains [25] by pouring culture onto the feeding trough daily for 4 d. On day 21, all birds were weighed and macroscopic lesions were recorded for NE, as described above.
Experiments 3 and 4
Based on the results of experiments 1 and 2, larger experiments were completed to further test NE induction models. Diclazuril (1 ppm) was included in the basal diet for all groups beginning on day of hatch, and removed from all groups, except NC, on day 14, 2 d prior to EM administration. For experiment 3, 490 day-old broilers were randomly assigned to one of the following treatments: NC (n = 70), CP1 with EMG (n = 60), CP1 with EM strain M6 (EMM6; n = 60), CP1, CPB1, CPB2, CPB3, CPB1-3 combination supernatant (supernatant), or CPB1-3 combination washed bacteria (washed), with n = 40 each. Explanation of challenges is described in Table 3 .
On day 20, a subset of birds (n = 20) from the EM challenge groups were not challenged with CP1 to measure the effect of EM on body weight gained (BWG) and coccidial lesion scores [32] . On day 21, these EM-only birds plus 10 birds from NC were selected for EM lesion scoring and BW measurement. On day 22, 20 birds from each treatment were euthanized and NE lesion scores were recorded. Weight parameters calculated included BWG to quantify changes in BW due to the EM and NE challenge and the percent BWG changed relative to NC. Experiment 4 was similar to experiment 3, with treatments described in Table 3 . Prior to each day of CP challenge, beginning day 17, feed was removed 6 h prior to challenge to encourage consumption of contaminated feed, plus feed trays were distributed in all corners of the pen, to ensure all birds had access to CP contaminated feed. A subset of the EM-challenged birds, similar to experiment 3, were not challenged with CP1 and were weighed and lesion scored on day 21. The same weight parameters as experiment 3 were calculated.
Statistical Analysis
Body weight and BWG data were subjected to a 1-way analysis of variance as a completely randomized design using the general linear models procedure of SAS [33] . The % BWG change, relative to NC, was calculated as {(BWG/average NC BWG%) −1} × 100. As described in previous literature, lesion score data were analyzed using a Proc Mixed ANOVA model [34] . Significant differences among all means were determined by Tukey's Honestly Significant Difference test at P ≤ 0.05 [35, 36] .
RESULTS AND DISCUSSION
Toxin Gene Detection
Clostridium perfringens has been shown to produce an array of toxins, though alpha-toxin (cpa gene) is present in all type A strains associated with NE, and has long been considered a major virulence factor [37, 38] . Within the last decade, it has been proposed that NetB toxincontaining strains of CP can cause NE [39] . However, the NetB research models place birds on heavy fish or meat and bone meal diets, sometimes up to 50%, which is a known predisposing factor of NE, but such high levels are not indicative of industry practice [39, 40] . To further test the role of NetB, 7 CP isolates from different NE outbreaks, including the isolates used in these experiments, were tested for the presence or absence of expression from key genes. Selected strains were then tested with a standard corn-soy diet absent of animal protein. Table 1 shows the primer selection to identify the targeted genes and PCR detection results. The cpa gene was present in all CP strains, as well as 16 s rRNA and glycoside hydrolase (cpgh84c), which encodes the carbohydrate 32 binding motif family [27, 41, 42] . The isolates CP1 thru CP3 were determined to be CP Type A based on the presence of cpa expression while CPB1 thru CPB4 isolates were determined to be CP Type C as these isolates contained cpa, cpb, and netB genes. Based on these results, CP1 and CPB1-3 were selected for in vivo testing.
Growth Performance
In experiment 1, NE was not controlled by the inclusion of BMD at 50 g/ton. The BMD treatment had the most severe % BWG change at a loss of −21.22 ± 2.18 (P = 0.043, compared to NC), as reported in Table 3 . This may be due to the heavy reliance of EMG for induction in this treatment group, since BMD was not expected to affect protozoa. The EMG and BMD groups had equivalent % BWG at 27.96 ± 0.49 and 27.11 ± 0.75, respectively. Multiple research models exist for studying NE in broilers, however, some may not be indicative of industry NE. A common method to induce NE is the combination of EM and CP [9, 43] . Outbreaks of NE have been reported to occur independent of EM, and have said to be related to CP strains that produce NetB toxin [44] . However, for this experiment, the one-time dose of CPB1 on day 19 did not change the BW parameters in the CPB1 group (Table 3) .
In experiment 2, the NC had the lowest final BW and % BWG compared to any treatment that had an inclusion of CP in the feed for 4 d (P = 0.045), as seen in Table 3 . A possible reason for low BW in the NC is that the birds were not sex separated, and there were more females in the NC (13/20) than any other group which ranged from 9 to 10 females per treatment, which was recorded at the end of the experiment. Even with an imbalanced sex ratio, 50 mL of 10 8 CFU/mL of CP per day for 4 d in the feed had no effect on BW parameters (Table 3 ). To test if to EMG and EMM6, experiment 4. 5 EMG = Eimeria maxima Guelph strain; EMM6 = Eimeria maxima M6 strain. 6 All CPB cultures were not washed by centrifugation unless indicated. 7 Combined with one kg of feed for administration to chickens.
a lack of pathology in experiment 2 was related to low dose, the amount of CP was increased to 100 mL per day for experiment 3, and there was little to no effect on BW parameters, with up to 9.28 ± 1.05 percent less BWG, or about 30 g less, for CPB2 compared to NC (P = 0.059; Table 4 ). Other researchers have included more CP into the feed, up to 1.25-2:1 ratio of CP to feed for several consecutive days [29, 45] . Often in NE challenge experimental models, birds were feed restricted for up to 24 h ensure optimal consumption of CP each day and CP in the feed resulted in paste-like substance with approximately 10 8 CFU/mL [29, 39, 46, 47] . Feed restriction can result in increased intestinal permeability; thus, birds may be susceptible to pathogen infiltration [48] . Without feed restricting the birds prior to challenge in experiments 2 and 3, the birds may not have consumed enough CP to proliferate to sufficient levels to cause disease, which did not result in the onset of NE. Though the advantage of this model was reduced animal handling, an NE model that requires excessive amounts of CP for several consecutive days may not be duplicative of industry-relevant NE illness, and does not indicate an actual CP infection. Rather, it may represent toxin production by CP as it passed through the GIT, and resulting disease may have been a toxemia rather than infection. While toxins are the ultimate cause of NE, the need to induce disease by these extreme measures suggests that the methods employed did not create a field-like condition of overgrowth of CP in the small intestine, as it is very unlikely that birds in production houses would ever be exposed to inoculum of this magnitude. This point could be argued as semantics, but given the complexity of (Tables 4 and 5 ). The CPB1 low group, which was the same treatment as CPB1 in experiment 3, did not significantly change the final BW or BWG of birds compared to NC. Administering CPB1 unwashed, which included end products of microbial growth, resulted in birds having a decreased % BWG change of −17.08 ± 1.64 or approximately 87 g decrease in BWG relative to NC from day 16 to 22, (P = 0.013), which was not different than EMG treatment (Table 4) . Treatment with the bacteria alone, CPB1 washed, affected % BWG change at −13.35 ± 2.32 or approximately 74 g decrease in BWG (P = 0.015).
A lack of change in BW (Table 4 ) and lesions (Table 6 ) in the supernatant group of experiment 4 suggests that CP did not produce adequate amount of toxins during in vitro growth and that in vivo colonization is an important factor in development of NE. A study found that when 14 NetB-positive CP isolates from healthy birds were cultured in vitro, less than 30% of the isolates produced the NetB toxin [54] . However, birds infected with NetB-positive CP developed NE and a majority of the isolates produced the NetB toxin in vivo. Similar results were reported in a toxin production study with beta2-toxin [55] . Generally, toxins function to facilitate the acquisition of essential nutrients from the environment, and nutrient-rich TSB likely provided sufficient nitrogenous and energy sources, such that toxin production was not stimulated in these CP strains during in vitro growth. Thus, the presence of a netB gene may not accurately represent pathogenicity of a CP isolate, but rather a potential phenotype that may contribute to the onset of NE [54] .
A key observation in this study was that CP only groups did not show clinical signs or macroscopic lesions of NE across all experiments (Table 6 , data not shown experiments 1 and 2). The decrease in BW parameters in these groups may have been caused by dysbacteriosis, rather than the onset of NE, though this condition was not specifically evaluated in these experiments. Dysbacteriosis is defined as abnormal microbiota within the small intestine which leads to reduced nutrient digestibility and impaired intestinal barrier function, which can lead to an increased inflammatory response [56] . A potential change in microbiota composition caused by administering copious amounts of CP in the feed for several consecutive days may cause NE-like clinical signs when other predisposing factors are present, such as increased protein or non-starch polysaccharide-containing ingredients [29, 57] . Animal-based protein is particularly popular in NE studies, and increased Group treatments described in Table 2 . Macroscopic NE lesion score scale reported as number of birds in the respective score/total birds lesion score in group. Mean lesion score reported as mean ± standard error. a,b,c,d Different superscripts within columns indicate significant difference at P < 0.05.
fishmeal in the diet has been shown to increase levels of CP in the GIT [58] . Fishmeal contains most of the essential amino acids that CP needs to proliferate and providing it in the diet may increase reproducibility of NE in research settings [59] . Though, NE research methods that involve extensive administration of CP and severe diet changes may not be typical of standard US production practices [15, 60, 61] .
To evaluate the impact of EM on NE, BW was measured individually at day 16, at the time of EMG, or EMM6 administration in experiments 3 and 4, and was measured by weighing birds again prior to CP1 strain challenge on day 20, while the effect of both EM and CP on BW was measured on day 22. For experiment 3, EMG and EMM6 treatments had a decrease in % BWG compared to NC day 20 and EM strain M6 caused more severe % BWG change (−2.74 ± 0.97; −8.98 ± 1.32, respectively P ≤ 0.040; Table 5 ). By day 22, 2 d post CP challenge, the dual infection groups had severely less BWG compared to the NC. As shown on Table 5 , EMG and EMM6 groups gained approximately 90-110 g less during the 48 h CP challenge period, thereby their % BWG change decreased by 66.08 ± 6.22 and 79.24 ± 6.07, respectively, compared to the NC (P ≤ 0.0001). Administering the same CP1 inoculum alone did not cause a change in BWG in the CP1 group. Experiment 4 had very similar results as experiment 3, administration of EM strain M6 caused 7.52 ± 1.51% less BWG by day 20 (P = 0.022) while EM strain Guelph at 0.23 ± 1.67% less BWG was not different from NC (Table 5) . Once strain CP1 was administered, the BWG was dramatically reduced in both EMG and EMM6 groups with % BWG change at −91.50 ± 7.86 and −72.30 ± 5.50, respectively, relative to the NC in the CP challenge effect period (P ≤ 0.0001).
Mild infections of Eimeria can result in slight reduction of BWG, while severe infections may result in differences upwards of 60% in BWG, and mortality is not uncommon [62] . Infections arise as EM disrupts the intestinal mucosa when schizonts rupture from epithelial cells and merozoites are released, which either infect neighboring enterocytes or develop into male and female gametes to produce oocysts. By 4 d post challenge, EM lifecycle could have upwards of 3 generations which would lead to compromised intestinal integrity and decreased digestive activity [63] [64] [65] [66] . In these studies, EM had only a mild impact on BW prior to CP challenge (Table 5) .
NE Lesion Scores
Clinical signs compatible with NE such as ruffled feathers, diarrhea, and decreased mobility were observed in the dual infection EM plus CP groups [67] . In experiment 1, NC group had the lowest lesion score with a mean of 0.15 ± 0.10 which was lower than CPB1 (P = 0.048), EMG, and BMD which had scores of 1.00 ± 0.25, 1.25 ± 0.35, and 1.31 ± 0.31, respectively, data not shown. The addition of BMD alone has been shown to reduce NE lesion scores, which may prevent dysbacteriosis in the GIT caused by CP [68] . Therefore, in this experiment, CP in the chicken GIT which proliferates due to preexisting injury caused by EM may have been resistant to BMD, though the CP isolate was not tested for resistance. Since there was no difference in the % BWG change or lesion score severity between NC and CPB1 with a 1-time CP dose, it was hypothesized that intermittent doses of CP across multiple days at 2-3 wk of age may result in greater differences between control and challenged groups. Several labs have concluded that CP must be provided for consecutive days either in the feed or by oral gavage [29, 57, 69, 70] . This abundance of CP may adhere to the intestinal mucosa, grow exponentially, and produce toxins, and ultimately result in macroscopic lesions [71, 72] . Increased volume of CP, 50 mL on feed troughs for 4 d, in experiment 2 did not produce clinical NE, and mean lesion scores ranged from 0.25 to 0.63 (P = 0.089, data not shown).
In experiments 3 and 4, the birds that were only challenged with strain EMG or EMM6 and were necropsied on day 21 had minimal coccidiosis lesions, with a mean of 1.0 and were not different than NC (data not shown). Though, results of experiment 3 showed NE lesions were most severe in treatments with preexisting coccidial infection regardless of EM strain (Table 6). Groups that included EM were the only ones to exhibit clinical signs of NE, in which mean lesion scores ranged from 2.95 to 3.11, and were the only groups that received scores of 4 (Table 6 ). Treatments with NetB-positive CP alone had reduced lesions compared to EMM6 (P = 0.042; Table 6 ). Though both CP1 and CPB3 had statistically higher lesion scores than NC, a lack of difference in BWG (Table 4) suggests that CP alone does not produce clinical NE [73] . Studies that produced clinical NE using NetB-producing CP with severe macroscopic lesions typically included a 28-50% fishmeal diet during the disease period and are not practical for studying industry parameters [39, 44] . The elevated bacterial exposure may have caused the inflammation and malabsorption of nutrients indicative of dysbacteriosis rather than NE [56] .
The EMG and EMM6 groups had similar results in experiment 4 with NE lesions ranging from 2.37 to 2.70 and were the only groups to receive scores of 3 and 4 (P = 0.001; Table 6 ). Lesion scores in all CPB1-based treatments were not statistically different from NC, with a range of 0.10 to 0.55 (Table 6) [56]. The intestines of the CPB1 unwashed and washed groups were observed as fragile with watery content, which are classical signs of dysbacteriosis and would explain the changes in BWG (Table 4) .
CONCLUSIONS AND APPLICATIONS
1. Necrotic enteritis research models that heavily rely on copious amounts of CP or improper use of feed ingredients do not provide a model that relevant based on current US production practices. While these methods may be relevant in regions where animal protein is typically included in diets, producers should be aware of models that do not mimic their production practices. 2. Exposing chickens to a NetB-negative strain of CP with preexisting EM reproduced subclinical NE in all experiments, and also had the greatest impact on BWG. This suggests that EM may be a more important factor in development of clinical NE than NetB toxin. 3. Without fishmeal or other predisposing factors in the feed, NetB-positive CP alone resulted in a mild decrease in BWG in experiments 3 and 4. However, the lack of NE macroscopic lesions indicated that the reduced BWG may have been caused by dysbacteriosis, influenced by the excessive amount of CP provided for several days. 4. In vitro CP toxin production likely was not at the level required to cause NE. Since CPB1 supernatant did not reduce BW or cause lesions, it can be concluded that an event or conditions within the GIT must induce a toxin-producing phenotype in order to cause NE.
24. Thioglycolate acid sodium salt. At 1% volume. Amresco. Solon, OH, USA.
25. CP bacterial preparation. Post-incubation, cells were washed three times in sterile saline by centrifugation at 3000 RPM x g for 15 min. The approximate concentration of SE was quantified spectrophotometrically at 625 nm at OD = 0.147 to approximate 1 × 10 8 CFU/mL followed by serial dilutions in sterile saline for the desired inoculum. Additionally, this concentration was also determined retrospectively, by serial dilution plating on tryptic soy agar with sodium thioglycalate and is reported in the data tables.
26 • C and gently shaken 3 days per week promote aeration. Oocysts per mL of solution were quantified by first removing the 2.5% potassium dichromate that preserved the oocysts by centrifugation. Next, oocysts were floated in a saturated salt solution and about 1 mL of suspended oocysts were inserted into a McMaster chamber, and the number of sporulated oocysts were calculated as number of oocysts per mL solution. Oocysts were then resuspended to the desired challenged dose in distilled water. 
